1,228
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Pertussis in Italy: how to protect the “unprotectable”?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1136-1141 | Received 28 May 2020, Accepted 04 Aug 2020, Published online: 29 Oct 2020

References

  • Frassanito A, Nenna R, Nicolai A, Pierangeli A, Tozzi AE, Stefanelli P, Carsetti R, Concato C, Schiavoni I, Midulla F, et al. Pertussis study group. Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections. BMC Infect Dis. 2017;17:492. doi:10.1186/s12879-017-2567-6.
  • Tozzi AE, Pandolfi E, Celentano LP, Massari M, Salmaso S. Ciofi degli Atti ML, EUVAC-NET study group. Comparison of pertussis surveillance systems in Europe. Vaccine. 2007;25:291–97. doi:10.1016/j.vaccine.2006.07.023.
  • Fedele G, Stefanelli P. Pertussis in infants and the resurgence of a vaccine preventable disease: what to do? Comment Ann Ist Super Sanita. 2017;53:100–03. doi:10.4415/ANN_17_02_04.
  • Masseria C, Martin CK, Krishnarajah G, Becker LK, Buikema A, Tan TQ. Incidence and burden of pertussis among infants less than 1 year of age. Pediatr Infect Dis J. 2017 Mar;36:e54–e61. doi:10.1097/INF.0000000000001440.
  • Carloni I, Ricci S, Azzari C, Galletti S, Faldella G, de Benedictis FM. Fatal pertussis in infancy, Italy. J Infect. 2017;75(2):186–89. doi:10.1016/j.jinf.2017.04.005.
  • Cherry JD. Pertussis in Young Infants Throughout the World. Clin Infect Dis. 2016;63:S119–S122. doi:10.1093/cid/ciw550.
  • Ministry of Health. Vaccine scheduler. [accessed 2019 Nov 9]. http://www.salute.gov.it/imgs/C_17_pagineAree_4829_listaFile_itemName_0_file.pdf
  • Fiasca F, Gabutti G. Mattei a trends in hospital admissions for pertussis infection: a nationwide retrospective observational study in Italy, 2002-2016. Int J Environ Res Public Health. 2019;16:E4531. doi:10.3390/ijerph16224531.
  • Italian Institute of Statistics. [accessed 2019 Dec 2]. http://demo.istat.it/MinistryofHealth. Vaccination coverage. [accessed 2019 Dec10]. http://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20
  • Gonfiantini MV, Carloni E, Gesualdo F, Pandolfi E, Agricola E, Rizzuto E, Iannazzo S, Ciofi Degli Atti ML, Villani A, Tozzi AE. Epidemiology of pertussis in Italy: disease trends over the last century. Euro Surveill. 2014;19:20921. doi:10.2807/1560-7917.es2014.19.40.20921.
  • Vittucci AC, Spuri Vennarucci V, Grandin A, Russo C, Lancella L, Tozzi AE, Bartuli A, Villani A. Pertussis in infants: an underestimated disease. BMC Infect Dis. 2016;16:414. doi:10.1186/s12879-016-1710-0.
  • Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi AE, Zanetti A, Zuccotti G. Pertussis. Hum Vaccin Immunother. 2015;11(1):108–17. doi:10.4161/hv.34364.
  • Forsyth K, Plotkin S, Tan T, Wirsing von König CH. Strategies to decrease pertussis transmission to infants. Pediatrics. 2015;135:e1475–1482. doi:10.1542/peds.2014-3925.
  • Nicolai A, Nenna R, Stefanelli P, Carannante A, Schiavariello C, Pierangeli A, Scagnolari C, Moretti C, Papoff P, Bonci E, et al. Bordetella pertussis in infants hospitalized for acute respiratory symptoms remains a concern. BMC Infect Dis. 2013;13:526. doi:10.1186/1471-2334-13-526.
  • Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. California pertussis epidemic, 2010. J Pediatr. 2012;161:1091–96. doi:10.1016/j.jpeds.2012.05.041.
  • Public Health England (PHE). Public health England (PHE) enhanced pertussis surveillance. [accessed 2020 Jan 21]. https://webarchive.nationalarchives.gov.uk/20140722070137/http://www.hpa.org.uk/hpr/archives/2013/news0513.htm#prtsss
  • Fedele G, Carollo M, Palazzo R, Stefanelli P, Pandolfi E, Gesualdo F, Tozzi AE, Carsetti R, Villani A, Nicolai A, et al. Parents as source of pertussis transmission in hospitalized young infants. Infection. 2017;45:171–78. doi:10.1007/s15010-016-0943-6.
  • Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014;111:787–92. doi:10.1073/pnas.1314688110.
  • Storsaeter J, Hallander H, Farrington CP, Olin P, Möllby R, Miller E. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine. 1990;8:457–61. doi:10.1016/0264-410x(90)90246-i.
  • von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr. 2010;169:1119–22. doi:10.1007/s00431-010-1192-9.
  • Meregaglia M, Ferrara L, Melegaro A, Demicheli V. Parent “cocoon” immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy. Vaccine. 2013;31:1135–37. doi:10.1016/j.vaccine.2012.12.061.
  • Skoff TH, Blain AE, Watt J, Scherzinger K, McMahon M, Zansky SM, Kudish K, Cieslak PR, Lewis M, Shang N, et al. Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation. Clin Infect Dis. 2017;65:1977–83. doi:10.1093/cid/cix724.
  • Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, Andrews N. Sustained effectiveness of the maternal pertussis immunization program in england 3 years following introduction. Clin Infect Dis. 2016;63:S236–S243. doi:10.1093/cid/ciw559.
  • Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60:333–37. doi:10.1093/cid/ciu821.
  • van den Biggelaar AHJ, Poolman JT. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev Vaccines. 2016;15:69–80. doi:10.1586/14760584.2016.1105136.
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months. Advisory committee on immunization practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1424–26.
  • Public Health England (PHE). Vaccination against pertussis (whooping cough) for pregnant women-2014. [accessed 2020 Jan 8] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/529956/FV_JUNE_2016_PHE_pertussis_in_pregnancy_information_for_HP_.pdf
  • Eberhardt CS, Blanchard-Rohner G, Lemaître B, Boukrid M, Combescure C, Othenin-Girard V, Chilin A, Petre J, de Tejada BM, Siegrist CA. Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis. 2016;62:829–36. doi:10.1093/cid/ciw027.
  • Ministry of Health. Circular of 21 november 2018. Recommended vaccinations for women of childbearing and pregnancy. [accessed 2020 Feb 2] http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&codLeg=66751&parte=1%20&serie=null
  • Stefanelli P, Buttinelli G, Vacca P, Tozzi AE, Midulla F, Carsetti R, Fedele G, Villani A, Concato C, Pertussis Study Group. Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization. Hum Vaccin Immunother. 2017;13:1073–77. doi:10.1080/21645515.2016.1276139.
  • Fiasca F, Necozione S, Fabiani L, Mastrodomenico M, Mattei A. Measles-related hospitalizations in Italy, 2004-2016: the importance of high vaccination coverage. Ann Glob Health. 2019;85:40. doi:10.5334/aogh.2455.
  • Fiasca F, Mattei A, Vittorini P, Necozione S, Appetiti A, Angelone AM, Fabiani L. Bacterial meningitis hospitalizations after the 2009 L’Aquila earthquake: a retrospective observational study. Asian J Epidemiol. 2018;11:46–51. doi:10.3923/aje.2018.46.51.